Sarissa Capital Management LP Long-Term Concentrated

Location: Greenwich, CT

CIK: 0001577524 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value: $434M (100.0% shares, 0.0% debt)

Holdings (14)

— ARIAD PHARMACEUTICALS INC 40.5%

Value $176M Shares 12,850,000 Est. Cost $6.73 Unrealized —

BIIB BIOGEN INC 22.3%

Value $97.04M Shares 310,000 Est. Cost $287.35 Unrealized +3.1%

— MEDICINES CO 15.2%

Value $66.12M Shares 1,752,000 Est. Cost $29.63 Unrealized —

— ARRAY BIOPHARMA INC 6.7%

Value $29.02M Shares 4,300,000 Est. Cost $3.36 Unrealized —

PCRX PACIRA PHARMACEUTICALS INC 3.4%

Value $14.71M Shares 430,000 Est. Cost $57.93 Unrealized -32.4%

INVA INNOVIVA INC 2.5%

Value $10.99M Shares 1,000,000 Est. Cost $11.67 Unrealized 0.0%

— INTRA CELLULAR THERAPIES INC 2.4%

Value $10.29M Shares 675,000 Est. Cost $27.96 Unrealized —

— AEGERION PHARMACEUTICALS INC 1.8%

Value $7.867M Shares 2,649,000 Est. Cost $21.95 Unrealized —

— ADVAXIS INC 1.5%

Value $6.413M Shares 600,000 Est. Cost $8.09 Unrealized —

— APRICUS BIOSCIENCES INC 1.1%

Value $4.898M Shares 14,479,052 Est. Cost $1.10 Unrealized —

DGX QUEST DIAGNOSTICS INC 1.0%

Value $4.231M Shares 50,000 Est. Cost $46.05 Unrealized +51.6%

— VIVUS INC 0.7%

Value $2.934M Shares 2,573,943 Est. Cost $9.08 Unrealized —

ABBV ABBVIE INC. 0.5%

Value $2.018M Shares 32,000 Est. Cost $38.85 Unrealized +13.1%

— AVEO PHARMACEUTICALS INC 0.4%

Value $1.78M Shares 2,000,000 Est. Cost $1.84 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	ARIAD PHARMACEUTICALS INC	12,850,000	$176M	40.5%	$6.73	—	COM	04033A100
BIIB	BIOGEN INC	310,000	$97.04M	22.3%	$287.35	+3.1%	COM	09062X103
—	MEDICINES CO	1,752,000	$66.12M	15.2%	$29.63	—	COM	584688105
—	ARRAY BIOPHARMA INC	4,300,000	$29.02M	6.7%	$3.36	—	COM	04269X105
PCRX	PACIRA PHARMACEUTICALS INC	430,000	$14.71M	3.4%	$57.93	-32.4%	COM	695127100
INVA	INNOVIVA INC	1,000,000	$10.99M	2.5%	$11.67	0.0%	COM	45781M101
—	INTRA CELLULAR THERAPIES INC	675,000	$10.29M	2.4%	$27.96	—	COM	46116X101
—	AEGERION PHARMACEUTICALS INC	2,649,000	$7.867M	1.8%	$21.95	—	COM	00767E102
—	ADVAXIS INC	600,000	$6.413M	1.5%	$8.09	—	COM NEW	007624208
—	APRICUS BIOSCIENCES INC	14,479,052	$4.898M	1.1%	$1.10	—	COM	03832V109
DGX	QUEST DIAGNOSTICS INC	50,000	$4.231M	1.0%	$46.05	+51.6%	COM	74834L100
—	VIVUS INC	2,573,943	$2.934M	0.7%	$9.08	—	COM	928551100
ABBV	ABBVIE INC.	32,000	$2.018M	0.5%	$38.85	+13.1%	COM	00287Y109
—	AVEO PHARMACEUTICALS INC	2,000,000	$1.78M	0.4%	$1.84	—	COM	053588109